Beauvericin and enniatin B1: an in vitro integrated approach for risk assessment. (September 2021) - Caloni, F.; Sambuy, Y.; Ranaldi, G.; Ferruzza, S.; Torri, E.; Vargiu, M.; Bertero, A.